Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial

Efficacy of N-Acetylcysteine Augmentation on Obsessive Compulsive Disorder: A Multicenter Randomized Double Blind Placebo Controlled Clinical Trial

Objective: Glutamate is considered a target for treating obsessive-compulsive disorder (OCD). The efficacy and safety of the nutritional supplement of N-Acetylcysteine (NAC) as an adjuvant to serotonin reuptake inhibitor (SSRI) for treating children and adolescents with OCD has never been examined....

Full description

Bibliographic Details
Main Authors: Ahmad Ghanizadeh, Mohammad Reza Mohammadi, Shahla Bahraini, Zahra Keshavarzi, Ali Firoozabadi, Ali Alavi Shoshtari
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2017-04-01
Series:Iranian Journal of Psychiatry
Subjects:
N-Acetylcysteine
Adjuvant
Obsessive Compulsive Disorder
Treatment
Clinical Trial
Placebo
Online Access:https://ijps.tums.ac.ir/index.php/ijps/article/view/1040

Internet

https://ijps.tums.ac.ir/index.php/ijps/article/view/1040

Similar Items